Your browser doesn't support javascript.
loading
Lercanidipine boosts the efficacy of mesenchymal stem cell therapy in 3-NP-induced Huntington's disease model rats via modulation of the calcium/calcineurin/NFATc4 and Wnt/ß-catenin signalling pathways.
Elbaz, Eman M; Helmy, Hebatullah S; El-Sahar, Ayman E; Saad, Muhammed A; Sayed, Rabab H.
Afiliação
  • Elbaz EM; Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
  • Helmy HS; Department of Biochemistry, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
  • El-Sahar AE; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
  • Saad MA; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt; School of Pharmacy, Newgiza University, Cairo, Egypt.
  • Sayed RH; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt. Electronic address: rabab.sayed@pharma.cu.edu.eg.
Neurochem Int ; 131: 104548, 2019 12.
Article em En | MEDLINE | ID: mdl-31539560

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Di-Hidropiridinas / Bloqueadores dos Canais de Cálcio / Transdução de Sinais / Doença de Huntington / Transplante de Células-Tronco Mesenquimais Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Di-Hidropiridinas / Bloqueadores dos Canais de Cálcio / Transdução de Sinais / Doença de Huntington / Transplante de Células-Tronco Mesenquimais Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Ano de publicação: 2019 Tipo de documento: Article